Vantage Investment Partners Llc increased Travelers Cos Inc/The (TRV) stake by 8.29% reported in 2017Q3 SEC filing. Vantage Investment Partners Llc acquired 8,429 shares as Travelers Cos Inc/The (TRV)’s stock declined 0.95%. The Vantage Investment Partners Llc holds 110,150 shares with $13.50 million value, up from 101,721 last quarter. Travelers Cos Inc/The now has $37.71B valuation. The stock decreased 1.57% or $2.21 during the last trading session, reaching $138.95. About 760,812 shares traded. The Travelers Companies, Inc. (NYSE:TRV) has risen 9.71% since February 20, 2017 and is uptrending. It has underperformed by 6.99% the S&P500.
Genmark Diagnostics Incorporated (NASDAQ:GNMK) had an increase of 2.98% in short interest. GNMK’s SI was 8.02M shares in February as released by FINRA. Its up 2.98% from 7.78M shares previously. With 485,500 avg volume, 17 days are for Genmark Diagnostics Incorporated (NASDAQ:GNMK)’s short sellers to cover GNMK’s short positions. The SI to Genmark Diagnostics Incorporated’s float is 19.2%. The stock decreased 0.22% or $0.01 during the last trading session, reaching $4.48. About 178,116 shares traded. GenMark Diagnostics, Inc. (NASDAQ:GNMK) has risen 116.11% since February 20, 2017 and is uptrending. It has outperformed by 99.41% the S&P500.
Vantage Investment Partners Llc decreased United Technologies Corp (NYSE:UTX) stake by 3,716 shares to 102,579 valued at $11.91M in 2017Q3. It also reduced Shaw Communications Inc (NYSE:SJR) stake by 23,045 shares and now owns 556,484 shares. 3M Co (NYSE:MMM) was reduced too.
Among 17 analysts covering Travelers (NYSE:TRV), 6 have Buy rating, 2 Sell and 9 Hold. Therefore 35% are positive. Travelers had 53 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Hold” rating by Keefe Bruyette & Woods on Wednesday, September 20. The firm has “Buy” rating by Keefe Bruyette & Woods given on Monday, October 16. The firm earned “Underweight” rating on Friday, October 20 by Morgan Stanley. The firm has “Neutral” rating by Atlantic Securities given on Friday, January 26. On Friday, January 22 the stock rating was maintained by RBC Capital Markets with “Outperform”. The stock has “Buy” rating by Citigroup on Friday, October 20. The stock of The Travelers Companies, Inc. (NYSE:TRV) earned “Outperform” rating by RBC Capital Markets on Wednesday, July 22. The stock has “Buy” rating by Bank of America on Tuesday, June 28. The firm earned “Neutral” rating on Wednesday, October 21 by Citigroup. Goldman Sachs maintained the shares of TRV in report on Tuesday, April 26 with “Neutral” rating.
Among 6 analysts covering Genmark Diagnostics (NASDAQ:GNMK), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Genmark Diagnostics had 19 analyst reports since October 14, 2015 according to SRatingsIntel. Needham maintained GenMark Diagnostics, Inc. (NASDAQ:GNMK) on Friday, January 19 with “Buy” rating. Needham maintained the shares of GNMK in report on Wednesday, August 2 with “Buy” rating. Canaccord Genuity maintained the stock with “Buy” rating in Monday, August 7 report. The rating was maintained by Canaccord Genuity with “Buy” on Monday, June 12. Needham maintained it with “Buy” rating and $1700 target in Monday, June 12 report. As per Friday, November 3, the company rating was downgraded by Raymond James. The stock has “Buy” rating by Canaccord Genuity on Friday, November 3. As per Tuesday, January 24, the company rating was maintained by Needham. Needham maintained it with “Buy” rating and $11 target in Wednesday, February 24 report. On Wednesday, October 18 the stock rating was maintained by Needham with “Buy”.
Since August 21, 2017, it had 0 insider buys, and 12 insider sales for $427,182 activity. Williams Jennifer Anne sold 365 shares worth $1,872. 148 GenMark Diagnostics, Inc. (NASDAQ:GNMK) shares with value of $759 were sold by Kayyem Jon Faiz. Gleeson Michael sold 1,933 shares worth $18,267. 8,311 shares were sold by MASSARANY HANY, worth $78,539. Stier Eric sold 1,808 shares worth $17,086. 848 GenMark Diagnostics, Inc. (NASDAQ:GNMK) shares with value of $4,350 were sold by McNally James B.. $1,324 worth of GenMark Diagnostics, Inc. (NASDAQ:GNMK) shares were sold by Mendel Scott.